Andliena Tahiri

426 total citations
11 papers, 245 citations indexed

About

Andliena Tahiri is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Andliena Tahiri has authored 11 papers receiving a total of 245 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Andliena Tahiri's work include Estrogen and related hormone effects (3 papers), HER2/EGFR in Cancer Research (3 papers) and Cancer-related molecular mechanisms research (2 papers). Andliena Tahiri is often cited by papers focused on Estrogen and related hormone effects (3 papers), HER2/EGFR in Cancer Research (3 papers) and Cancer-related molecular mechanisms research (2 papers). Andliena Tahiri collaborates with scholars based in Norway, United States and Canada. Andliena Tahiri's co-authors include Vessela N. Kristensen, Jürgen Geisler, Miriam R. R. Aure, Ida Bukholm, Torben Lüders, Anne‐Lise Børresen‐Dale, Suvi‐Katri Leivonen, Kristine Kleivi Sahlberg, Israel Steinfeld and Rami Mäkelä and has published in prestigious journals such as PLoS ONE, Carcinogenesis and Journal of Thrombosis and Haemostasis.

In The Last Decade

Andliena Tahiri

11 papers receiving 243 citations

Peers

Andliena Tahiri

ONCOL

PRM

IMMUN

Chun-Lin Lin United States

Xiaoling Ling China

Shu‐Guang Su China

Xiaobing Le China

Edyta Vieth United States

Brianna C. Morten Australia

Jordan Shafran United States

Negin Taghehchian Iran

Jovana Klajic Norway

Ahmet Arslan Türkiye

Chun-Lin Lin United States

Andliena Tahiri

205 ×1.3

127 ×1.0

78 ×1.0

ONCOL

68 ×2.1

PRM

21 ×0.8

IMMUN

Citations per year, relative to Andliena Tahiri Andliena Tahiri (= 1×) peers Chun-Lin Lin

Countries citing papers authored by Andliena Tahiri

Since Specialization

Citations

This map shows the geographic impact of Andliena Tahiri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andliena Tahiri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andliena Tahiri more than expected).

Fields of papers citing papers by Andliena Tahiri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andliena Tahiri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andliena Tahiri. The network helps show where Andliena Tahiri may publish in the future.

Co-authorship network of co-authors of Andliena Tahiri

This figure shows the co-authorship network connecting the top 25 collaborators of Andliena Tahiri. A scholar is included among the top collaborators of Andliena Tahiri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andliena Tahiri. Andliena Tahiri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Tekpli, Xavier, Andliena Tahiri, Jürgen Geisler, et al.. (2024). The breast cancer coagulome in the tumor microenvironment and its role in prognosis and treatment response to chemotherapy. Journal of Thrombosis and Haemostasis. 22(5). 1319–1335. 9 indexed citations

Kumar, Surendra, Jürgen Geisler, Torben Lüders, et al.. (2024). Benign breast tumors may arise on different immunological backgrounds. Molecular Oncology. 18(10). 2495–2509. 1 indexed citations

Haugen, Mads H., Vesa Hongisto, Miriam R. R. Aure, et al.. (2023). High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer. PLoS ONE. 18(1). e0280507–e0280507. 5 indexed citations

Tahiri, Andliena, Vessela N. Kristensen, G. Cecilie Alfsen, et al.. (2022). Kinase activity profiling in renal cell carcinoma, benign renal tissue and in response to four different tyrosine kinase inhibitors. Oncotarget. 13(1). 970–981. 2 indexed citations

Tahiri, Andliena, Torill Sauer, Stephanie Geisler, et al.. (2021). Lack of cross-resistance between non-steroidal and steroidal aromatase inhibitors in breast cancer patients: the potential role of the adipokine leptin. Breast Cancer Research and Treatment. 190(3). 435–449. 10 indexed citations

Tahiri, Andliena, Xavier Tekpli, Somisetty V. Satheesh, et al.. (2020). Loss of progesterone receptor is associated with distinct tyrosine kinase profiles in breast cancer. Breast Cancer Research and Treatment. 183(3). 585–598. 11 indexed citations

Tahiri, Andliena, Miriam R. R. Aure, & Vessela N. Kristensen. (2018). MicroRNA Networks in Breast Cancer Cells. Methods in molecular biology. 1711. 55–81. 15 indexed citations

Quigley, David A., Andliena Tahiri, Torben Lüders, et al.. (2017). Age, estrogen, and immune response in breast adenocarcinoma and adjacent normal tissue. OncoImmunology. 6(11). e1356142–e1356142. 30 indexed citations

Dannenfelser, Ruth, Andliena Tahiri, Josie Ursini‐Siegel, et al.. (2017). Data-driven analysis of immune infiltrate in a large cohort of breast cancer and its association with disease progression, ER activity, and genomic complexity. Oncotarget. 8(34). 57121–57133. 30 indexed citations

10.

Tahiri, Andliena, Kathrine Røe, Anne Hansen Ree, et al.. (2013). Differential Inhibition of Ex-Vivo Tumor Kinase Activity by Vemurafenib in BRAF(V600E) and BRAF Wild-Type Metastatic Malignant Melanoma. PLoS ONE. 8(8). e72692–e72692. 26 indexed citations

11.

Tahiri, Andliena, Suvi‐Katri Leivonen, Torben Lüders, et al.. (2013). Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors. Carcinogenesis. 35(1). 76–85. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact